EF - 医索

找到约 499 条结果

谁与争锋丨EFS HR 0.40，NEOTORCH研究树立围术期免疫治疗新标杆

引言：随着免疫治疗在晚期NSCLC治疗中取得优异疗效，其治疗领域进一步拓展至NSCLC围术期治疗，并成为目前国内外的热点议题。IMpower010和CheckMate 816研究分别奠定了免疫检查点抑制剂（ICI）在NSCLC辅助治疗和新辅助治疗中的地位，并相.....

学术资讯 - 面面观

The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer A Phase II Study

医客学院 - 药物研究

Health effects of the use of non-sugar sweeteners

医客学院 - 其他

ESMO Expert Consensus Statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

医客学院 - 药物研究

Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001) a single-arm, phase 2 trial

医客学院 - 药物研究

Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients with Resectable Non-Small-Cell Lung Cancer A Phase 2 Clinical Trial

医客学院 - 药物研究

slides-PD1_blockade_alone_for_mismatch_repair_deficient_d

医客学院 - 会议报告集

Trifluridinetipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer The phase 3 randomized SU

医客学院 - 会议报告集

The usefulness of indocyanine green (ICG)–guided lymphadenectomy in robotic gastrectomy for advanced gastric cancer

医客学院 - 会议报告集

The effect of potassium-competitive acid blocker tegoprazan on gastric cancer cells

医客学院 - 会议报告集

今日实时热搜